Contrôle et lutte contre la fraude du patient européen

Il est des chiffres qui donnent le vertige. Incontestablement, ceux concernant les pertes dues à la fraude et la corruption en matière de soins en font partie. Certaines estimations font en effet état de 56 milliards d'euros perdus annuellement en Europe, ce qui représente près de 80 millions de perte chaque jour et plus de 5% de l'ensemble des budgets nationaux consacrés à la santé (Gee et alii, 2010)

Language Use and Family Transmission in Migration Context

This chapter analyses the foreign language usage of migrants to France over the last 50 years. The TeO survey enables us to place language usage in the context of individual linguistic repertoires and migration trajectories, taking account of social characteristics and transnational practices. The use of languages other than French evolves in response to strong competition from the majority language. Moreover, many immigrants from countries with historical colonial links to France spoke French even before arriving in the country.After a first part devoted to immigrants’ linguistic skills and their command of French, the chapter then describes the profile of immigrants who continue to speak other languages, the context in which they use them, and the factors that favour their continued use, notably family transmission. The last part examines the extent to which family languages are mastered by descendants of immigrants after reaching adulthood. Placing different languages in perspective reveals the degree to which individuals acknowledge this transmission as a cultural inheritance and/or a resource that can also be mobilized outside the family sphere. Attitudes in this respect vary from one language to another

Molecular and clinicopathologic characterization of pediatric histiocytoses

International audienceThe spectrum of somatic mutations in pediatric histiocytoses and their clinical implications are not fully characterized, especially for non-Langerhans cell histiocytosis (-LCH) subtypes. A cohort of 415 children with histiocytosis from the French histiocytosis registry was reviewed and analyzed for BRAFV600E. Most BRAFWT samples were analyzed by next-generation sequencing (NGS) with a custom panel of genes for histiocytosis and myeloid neoplasia. Of 415 case samples, there were 366 LCH, 1 Erdheim-Chester disease, 21 Rosai-Dorfman disease (RDD), 21 juvenile xanthogranuloma (JXG, mostly with severe presentation), and 6 malignant histiocytosis (MH). BRAFV600E was the most common mutation found in LCH (50.3%, n = 184). Among 105 non-BRAFV600E-mutated LCH case samples, NGS revealed mutations as follows: MAP2K1 (n = 44), BRAF exon 12 deletions (n = 26), and duplications (n = 8), other BRAF V600 codon mutation (n = 4), and non-MAP-kinase pathway genes (n = 5). Wild-type sequences were identified in 17.1% of samples. BRAFV600E was the only variant significantly correlated with critical presentations: organ-risk involvement and neurodegeneration. MAP-kinase pathway mutations were identified in seven RDD (mostly MAP2K1) and three JXG samples, but most samples were wild-type on NGS. Finally, two MH samples had KRAS mutations, and one had a novel BRAFG469R mutation. Rarely, we identified mutations unrelated to MAP-kinase pathway genes. In conclusion, we characterized the mutational spectrum of childhood LCH and clinical correlations of variants and subtypes. Variants responsible for JXG and RDD were not elucidated in more than half of the cases, calling for other sequencing approaches